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Abstract
Background: Precise connections of neural circuits can be specified by genetic programming. In
the Drosophila olfactory system, projection neurons (PNs) send dendrites to single glomeruli in the
antenna lobe (AL) based upon lineage and birth order and send axons with stereotyped
terminations to higher olfactory centers. These decisions are likely specified by a PN-intrinsic
transcriptional code that regulates the expression of cell-surface molecules to instruct wiring
specificity.
Results:  We find that the loss of longitudinals lacking (lola), which encodes a BTB-Zn-finger
transcription factor with 20 predicted splice isoforms, results in wiring defects in both axons and
dendrites of all lineages of PNs. RNA in situ hybridization and quantitative RT-PCR suggest that
most if not all lola isoforms are expressed in all PNs, but different isoforms are expressed at widely
varying levels. Overexpression of individual lola isoforms fails to rescue the lola null phenotypes and
causes additional phenotypes. Loss of lola also results in ectopic expression of Gal4 drivers in
multiple cell types and in the loss of transcription factor gene lim1 expression in ventral PNs.
Conclusion: Our results indicate that lola is required for wiring of axons and dendrites of most
PN classes, and suggest a need for its molecular diversity. Expression pattern changes of Gal4
drivers in lola-/- clones imply that lola  normally represses the expression of these regulatory
elements in a subset of the cells surrounding the AL. We propose that Lola functions as a general
transcription factor that regulates the expression of multiple genes ultimately controlling PN
identity and wiring specificity.
Background
Nervous systems exhibit highly reproducible patterns of
connectivity that are essential for their proper functions.
Axon pathfinding in many systems is heavily dependent
upon genetically programmed expression of guidance fac-
tors and their receptors [1]. Recent studies have indicated
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that dendrite target selection and aspects of synapse spe-
cificity can also be precisely genetically programmed in
flies [2] and vertebrates [3]. For example, wiring specificity
in the adult Drosophila olfactory system is achieved during
pupal development before the onset of olfactory receptor
expression [4]. Olfactory receptor neurons (ORNs) project
their axons to glomeruli in the antennal lobe (AL), where
they synapse with the dendrites of projection neurons
(PNs) (Figure 1a; reviewed in [5,6]). PNs target their den-
drites to single glomeruli and send their axons to stereo-
typic locations in the mushroom body (MB) and lateral
horn (LH) according to their glomerular class [7-9]. Most
PNs are derived from three neuroblast lineages, antero-
dorsal (adPNs), lateral (lPNs) and ventral (vPNs). adPNs
and lPNs innervate intercalating but non-overlapping sets
of glomeruli, suggesting lineage-specific control of target-
ing. Additionally, adPNs are specified by birth order, sug-
gesting that instructive information within a lineage
determines wiring patterns [2]. Indeed, PN dendritic pat-
terning precedes ORN axon patterning: by the time pio-
neering ORN axons arrive at the developing AL, PN
dendrites have already formed a coarse map by virtue of
their specific dendritic targeting [4].
Several cell-surface proteins, including Sema-1a, Dscam
and N-Cadherin, have been shown to play different roles
in PN dendritic development. These studies suggest a
model in which PN dendrites first target to a rough region
of the AL based on molecular gradients and then are fur-
ther refined by dendro-dendritic and dendro-axonal inter-
actions [10-12]. The expression of these and additional
cell-surface proteins are likely controlled by a transcrip-
tional code that acts to uniquely specify the wiring apti-
tude of individual PNs[13,14]. Studies of several
transcription factors (TFs) support the existence of a tran-
scriptional hierarchy in PNs. Some factors, such as the
LIM cofactor Chip, appear to affect wiring in all PN classes
[14]. Other TFs show lineage specific restriction in expres-
sion and regulatory effects. For example, the LIM-homeo-
domain TF Islet is required for proper targeting of a subset
of adPNs and lPNs, while the homeodomain TF Cut is
required in only a subset of lPNs and all vPNs [14]. As
another example, POU-domain TFs Acj6 and Drifter have
restricted expression patterns in adPN and lPN lineages,
respectively, and control wiring specificity in their respec-
tive lineages [13]. A recently identified BTB-Zn-finger TF,
Chinmo, regulates birth order-dependent wiring of
adPNs. Loss of chinmo results in adPNs born in early larval
life acquiring the targeting specificity of late-born PNs
within the same lineage [15]. There are also TFs that
appear to affect targeting of a single PN type. For example,
the LIM-homeodomain TF Lim1 is necessary for proper
targeting of a single vPN to the DA1 glomerulus, and is
regulated by Cut. The Zn-finger TF Squeeze appears to be
necessary for the innervation of a single lPN glomerulus,
DM5 [14]. All these studies support a model where the
targeting specificity of a particular PN is regulated by a
unique complement of TFs, and additional members of
the TF code remain to be identified.
The gene longitudinals lacking (lola) encodes a molecularly
diverse BTB-Zn-finger TF with at least 20 unique protein
isoforms (Figure 1b). Each isoform is formed by combin-
ing a set of common BTB-containing amino-terminal
exons to unique Zn-finger-containing carboxy-terminal
exons via trans- and/or cis-pre-mRNA splicing [16-18]. The
BTB (Broad complex, Tramtrack, Bric à brac) domain, also
referred to as the POZ (poxvirus and Zn-finger) domain,
is a common domain likely involved in protein-protein
interactions [19]. Most lola isoforms have one or more
unique Zn-fingers of either the C2H2 type that binds DNA,
or the unusual C2HC class that binds nucleosomes, non-
histone proteins, RNA and DNA [20,21]. At least some
Lola isoforms bind DNA directly [22]. Interestingly, three
Lola isoforms lack Zn-fingers and theoretically could be
involved in heteromeric regulatory interactions with other
Lola isoforms, as Lola was found to bind itself in yeast-
two-hybrid interactions and co-immunoprecipitation
experiments [21,23]. Lola also likely interacts with other
proteins such as chromosomal kinase JIL-1 [21].
Lola was initially identified as a factor that regulates axon
guidance in the embryonic central nervous system longi-
tudinal tracks, and is reported to function in a wide array
of other cellular processes. lola mutants exhibit defects in
the extension of embryonic longitudinal axons and mid-
line crossing, orientation of lateral chordotonal neurons,
and ISNb axon growth and elaboration [24,25]. Mutation
of Lola isoforms K or L is sufficient to inactivate a specific
subset of lola functions in ISNb neurons, suggesting that
different Lola isoforms may have unique functions [16].
lola was recently identified to disrupt ORN axonal inner-
vation of the AL in an overexpression screen [26]. lola may
exert its effect through transcriptional regulation of cell-
surface molecules, and has been reported to genetically
interact with Notch, slit, and robo [27,28]. lola may have a
more general regulatory role as a polycomb group (PcG)
factor affecting cell proliferation via the Notch pathway
and regulating wing development through a genetic inter-
action with cut [29].
In this study, we show that lola plays an essential role in
PN identity and wiring specificity. lola appears to be a gen-
eral factor that affects wiring of both axons and dendrites
in all three lineages of PNs. Overexpression of UAS-lola T
and  UAS-lola L, but not UAS-lola A, results in wiring
defects. Additionally, expression of single lola isoforms is
insufficient to rescue the lola null phenotype and often
causes additional defects specific to the isoforms
expressed, suggesting the importance of Lola molecularNeural Development 2007, 2:14 http://www.neuraldevelopment.com/content/2/1/14
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The Drosophila olfactory system, the lola gene, and Lola expression Figure 1
The Drosophila olfactory system, the lola gene, and Lola expression. (a) Schematic representation of the Drosophila antennal 
lobe. Olfactory receptor neuron (ORN) axons project to stereotyped glomeruli in the antennal lobe (AL). The anterodorsal 
(ad), lateral (l) and ventral (v) lineages of Gal4-GH146 positive PNs send dendrites to specific glomeruli in the AL and axons to 
specific regions in the mushroom body (MB) calyx and lateral horn (LH). (b) Schematic representation of the lola gene. lola is a 
complex genetic locus consisting of at least 20 isoforms generated by both cis- and trans-splicing of an amino-terminal BTB 
domain-containing common region to unique carboxy-terminal exons, most of which contain Zn fingers. Individual isoforms 
are labeled in accordance with previous nomenclature [16]. Mutations are marked by asterisks and isoforms with UAS trans-
genes are listed. (c-g) Time course of Lola expression using an antibody generated against the common region (amino acids 
19–467). Lola is expressed in all neurons adjacent to the AL at all stages of development, shown at 24 h after larval hatching 
(ALH), 72 h ALH, 0 h after puparium formation (APF), 18 h APF and adult. Lola is also expressed in the neuroblast (arrow in c). 
In this and all subsequent figures, non-overlapping fluoresence channels are pseudocolored for ease of viewing: anti-CD8::GFP 
in green, anti-Lola in magenta. Dashed vertical line marks the midline. Antenna lobe (AL) outlined with thin dashed line in (g). 
(h, i) Specificity of anti-Lola antibody. Lateral lola-/- (ore76) MARCM clone stained with anti-pan Lola. In (h), the white outline 
denotes entire MARCM clone determined by loss of Lola staining. The yellow outline denotes boundary of GH146 positive 
cells based on GFP expression. Loss of Lola staining in GH146 cells can be seen clearly in the magenta (Lola) only channel (h2). 
In (i), a DL1 single-cell lola-/- MARCM clone shows a loss of Lola staining in the magenta channel (i2). The arrow marks the same 
cell in (i1) and (i2). Scale 10 μm. Green, anti-CD8::GFP; magenta, anti-Lola; blue, DAPI.
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diversity in regulating PN wiring specificity. Indeed most
lola isoforms are expressed in PNs but at different levels.
Finally, consistent with previous findings of transcrip-
tional regulation and potential PcG function, we find that
lola likely regulates lim1and several Gal4 enhancer trap
lines in PNs. We suggest that lola  regulates PN wiring
through transcriptional regulation of downstream targets
involved in defining neuronal identity and targeting spe-
cificity.
Results and discussion
We investigated the function of lola in wiring specificity of
olfactory PNs by using the MARCM (mosaic analysis with
a repressible cell marker) system [30]. PNs send dendrites
to specific glomeruli in the AL [2] and axons to the MB
and LH in highly stereotyped patterns [7-9] (Figure 1a),
allowing us to examine lola function in both dendrites
and axons.
Lola is expressed in projection neurons and neuroblasts
Using a specific antibody raised against the domain com-
mon to all Lola isoforms (Figure 1b), we found that Lola
is expressed in all cells in the AL region at all stages of
development from larva to adult (Figure 1c–g). These
include expression in post-mitotic cells such as PNs, but
also in neuroblasts, which we can identify by their size
during larval development (Figure 1c). Antibody specifi-
city was confirmed by loss of Lola staining in neuroblast
and single-cell MARCM clones homozygous for a lola null
allele (ore76, which introduces an early stop codon in the
BTB domain of all Lola isoforms (Figure 1b), hereafter
referred to as lola-/-) in adult (Figure 1h,i) and in early
pupa (data not shown). Note that Lola staining can be
used to identify all mutant cells in a MARCM clone that
are not necessarily labeled by UAS-mCD8::GFP because
Lola is expressed ubiquitously throughout the brain,
while Gal4 enhancer traps often have a more limited
domain of expression (Figure 1h).
lola mutant projection neurons have dendrite wiring 
defects
Since Lola is expressed in PNs during AL development,
and mutant clones effectively eliminate Lola protein dur-
ing the period of dendritic targeting, we proceeded to ana-
lyze the phenotype of lola-/- PN MARCM clones. Using the
Gal4-GH146 enhancer-trap line to label PNs, we observed
wiring defects in all lineages of PN MARCM clones as well
as anterodorsal single cell clones that normally target the
DL1 glomerulus (Figure 2).
In wild type, Gal4-GH146 labels PNs of three neuroblast
lineages. PNs from adPN and lPN lineages target their
dendrites to stereotypical, intercalating but non-overlap-
ping sets of glomeruli [2] (Figure 2a1,a2,c1). In general,
phenotypes of lola-/- adPNs and lPNs can be classified into
two main categories: a loss of targeting to normal target
glomeruli and a gain of targeting to off-target (ectopically
targeted) glomeruli (Figure 2b1,b2). However, the pheno-
types are highly variable between brains and there are few
consistent 'shifts' where one off-target glomerulus is
innervated in place of a normal target. The phenotypes
also have variable penetrance, with innervation of both
normal and ectopic targets ranging from partial to full
innervation from brain to brain. Specifically, lola-/- adPNs
often invade DA1, DL3 and VA4, which are normal lPN
targets. Likewise, mutant lPNs often innervate VA1d,
VA1lm, DM6, D, DC2 and VM7, which are normal adPN
targets (Figure 2c2). lola-/- dendrites also appear more dif-
fuse in general, and often 'wander' through the lobe,
wrapping around, but not actually innervating, glomeruli.
Additionally, lola-/- dendrites are frequently not restricted
to the AL and innervate regions of the suboesophageal
ganglion (SOG; Figure 2b1,b3,c2). Wild-type vPNs
strongly innervate DA1 and VA1lm, and one vPN (pan-AL
PN) innervates the entire AL (Figure 2a3). lola-/- vPNs
show a strong loss of AL restriction and nearly 37% show
ectopic dendritic extensions to the SOG (Figure 2b3,c2).
Additionally, DA1 targeting in ventral clones is almost
completely lost (6% versus 82% in wild type) and VA1lm
targeting is reduced nearly 30% (Figure 2c2). We also ana-
lyzed an independent lolaore5D2 allele of lola, which is pre-
dicted to be strongly hypomorphic due to a P-element
insertion in the lola promoter (Figure 1b). lolaore5D2 clones
display many of the phenotypes observed in the ore76 null
allele (see additional file 1), indicating that the pheno-
types we observed are caused by loss of lola.
Given that Lola is ubiquitously expressed, dendritic
defects in neuroblast clones can be attributed to its
requirement in the neuroblast or post-mitotic cells or
both; furthermore, one cannot determine cell autonomy
with certainty. We therefore examined single cell clones
that target to the DL1 glomerulus to test whether lola has
a cell-autonomous and post-mitotic function. We found
that nearly 80% of lola-/- DL1 single cell clones show tar-
geting defects (Figure 2b4,c2) and 23% completely fail to
innervate DL1. Another 54% innervate DL1 (though often
weakly or partially) and have additional extensions either
wandering between glomeruli or, more frequently, inner-
vating glomeruli anterior to DL1 in the AL (see Table S1 in
additional file 2). Using the pan-Lola antibody, we can
verify there are no unlabeled clones in the vicinity of the
AL and be certain we are looking at cell-autonomous
effects. At least in the DL1 PN, therefore, lola appears to
have post-mitotic, cell intrinsic effects on dendritic target-
ing.
To extend higher resolution phenotypic analysis to other
PN classes, we examined adPN and lPN neuroblast clones
using Gal4-Mz19, which labels a small subset of GH146-Neural Development 2007, 2:14 http://www.neuraldevelopment.com/content/2/1/14
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Dendritic targeting defects in lola-/- MARCM clones Figure 2
Dendritic targeting defects in lola-/- MARCM clones. Representative confocal images of (a) wild-type control and (b) lola-/- 
anterodorsal (1), lateral (2), or ventral (3) MARCM neuroblast (NB) clones or DL1 single cell (SC) clones (4) labeled with 
Gal4-GH146, and anterodorsal (5) and lateral (6) neuroblast clones labeled with Gal4-Mz19. Blue arrows and circles demark a 
loss of correct targeting, while yellow arrows and circles demark off-target innervation. Both anterodorsal and ventral lola-/-
clones have ectopic dendritic extensions to the suboesophageal ganglion (SOG). anti-CD8::GFP in green, anti-nc82 neuropil in 
magenta. Scale bar, 20 μm. (c1) Normal targets of Gal4-GH146 in anterior, middle and posterior sections of the AL. Red 
denotes dorsal target, blue denotes lateral target, and green denotes ventral target. (c2) Quantification of adNB, lNB, vNB and 
DL1 clone phenotypes. The percentage of clones targeting a particular glomerulus is denoted on the Y-axis, while individual 
glomeruli are listed on the X-axis and grouped according to lineage by color as in (c1). Glomeruli in orange are not normally 
targeted by Gal4-GH146 positive PNs by heatshocking at 24 h ALH. Control clone innervation is denoted by colored bars cor-
responding to lineage, and lola-/- clone innervation is denoted by black bars. Note the decrease of correct targeting and increase 
of off-target innervation in lola-/- brains for all clone types. Additionally, the final 'diffuse' bar quantifies the number of brains that 
exhibit diffuse and wandering dendrites that fail to specifically innervate glomeruli.
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positive neurons that project to DA1, VA1d and DC3 [4].
Interestingly, dendritic targeting of lola-/- DA1 and VA1d
PNs exhibit phenotypes with much less severity and pen-
etrance than other lola-/- PNs. Normal target glomeruli
were almost always strongly targeted, and defects mainly
consisted of additional dendritic extensions into the AL
(Figure 2b5,6). Consistent with this, we find that DA1
(innervated by lPNs) and VA1d (innervated by adPNs) are
two of the most 'stable' glomeruli and show little pheno-
type in GH146 mutant neuroblast clones (Figure 2c2).
These two glomeruli are also often ectopically innervated
by lola-/- PNs from the opposite lineage (that is, DA1 is
ectopically targeted by lola-/- adPNs while VA1d is ectopi-
cally targeted by lola-/- lPNs). This experiment suggests that
distinct PN classes differentially require lola.
We also tested available mutations that affect individual
lola isoforms. The orc4 (affecting isoform K; Figure 1b)
allele did not show obvious defects (see additional files 1,
4 and 8). The ore119 allele (affecting isoform L; Figure 1b)
shows a small subset of the phenotypes observed in lola-/-
(see additional file 1). lola L-/- adPN targeting appears nor-
mal, but lPNs show a loss of targeting to VM1 and DA2,
while ventral clones show a loss of DA1 targeting. How-
ever, we cannot rule out the possibility that an additional
mutation on the lola L mutant chromosome contributes
to the phenotype, as our attempts to generate a second
allele specific for lola L have not been successful and the
ore119 phenotype could not be rescued by a UAS-lola L
transgene (data not shown). In fact, MARCM expression
of lola L in PNs results in severe phenotypes by itself (see
below).
lola mutant projection neurons have axon wiring defects
In addition to dendritic phenotypes, we observed defects
in PN axonal wiring in lola-/- MARCM clones. As with den-
drites, defects were found in adPNs, lPNs and vPNs as well
as DL1 single-cell clones (Figure 3). Phenotypes were
highly variable both in penetrance and severity in neurob-
last as well as single cell clones. In a semi-quantitative
approach, we scored phenotypes as mild, medium and
severe (see Figure 3 legend). A separate quantification of
the targeting defects limited by specific phenotypes
(ectopic branching, misrouting of axons, SOG targeting
and a lack of MB/LH innervation) is presented in Table S2
(see additional file 2).
In lola-/- adPNs and lPNs, the most common defect was
ectopic branching outside of the region of the MB or the
LH (28% and 63%, respectively; Figure 3b1,2; see Table
S2 in additional file 2). Some clones showed a lack of
innervation, where innervation of the MB failed to occur
or branch extension in the LH was severely limited. A
smaller percentage of lola-/- clones (15% adPNs and 7%
PNs) showed medium or severe axon defects (Figure 3d).
Hypomorphic clones (ore5D2) show similar, but mostly
mild, targeting defects (see Table S2 in additional file 2).
Axons of vPNs are the most severely affected: nearly 100%
of clones exhibit defects in both lola-/- and hypomorphic
(ore5D2) alleles (Figure 3b3,d; see Table S2 and S4 in
additional file 2). Often ventral axons show several
defects in the same brain. Seventy-nine percent of lola-/-
clones show ectopic branching defects (often extensions
from the LH towards the SOG or an increase in branches
along the medial extension). Thirty-four percent of clones
show misrouting defects; most often a single axon defas-
ciculates from the bundle and projects directly to the
medial-central region of the LH instead of the ventral
region (compare Figure 3a3 to 3b3). Nine percent of null
clones and 47% of hypomorph clones show clear axonal
targeting to the SOG (this may be higher in the null but it
can be difficult to distinguish between axon and dendrite
mistargeting unless clear defasciculation from the main
axon bundle is visible). We observe that all PN axons exit
the AL in a single bundle, but then some axons defascicu-
late and project ventrally to the SOG (Figure 3c). It is
interesting to note that axons misguided to the SOG typi-
cally project to similar locations in the SOG, suggesting
they may be responding to some cues in this region.
More than 50% of DL1 single cell clones show axon
defects (Figure 3b4,d, see Table S3 in additional file 2),
suggesting that Lola acts cell-autonomously in axon tar-
geting. Twenty-six percent of DL1 lola-/- axons have ectopic
branches, often with additional branches in the LH region
(see Table S2 in additional file 2). Fifteen percent of
clones fail to extend branches into the MB (see Table S2 in
additional file 2). Some DL1 axons clearly bifurcate just
prior to entering the MB. It is interesting to note that many
DL1 clones that fail to target the DL1 glomerulus have rel-
atively normal axonal projections. A severe dendrite phe-
notype does not predict the most severe axon phenotypes
(or vice versa), suggesting that these two processes are sep-
arable, in agreement with recent observations of inde-
pendence between axon and dendrite targeting [14].
These results suggest that lola has post-mitotic, cell-auton-
omous functions in PN axon targeting.
Analysis of lola isoform expression by in situ hybridization 
and RT-PCR
Our MARCM analysis suggests that lola has an important
function for PN dendritic and axonal targeting. Given that
lola encodes 20 alternatively spliced isoforms, several sce-
narios may account for lola function (see additional file
3). In scenario I, different isoforms may be expressed in
different neuroblast lineages and thereby specify their lin-
eage-specific wiring analogous to POU transcription fac-
tors [13]. In scenario II, individual PNs may express a
unique isoform or combination of isoforms independentNeural Development 2007, 2:14 http://www.neuraldevelopment.com/content/2/1/14
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of lineage to specify PN identity. In scenario III, all cells
may express most or all lola isoforms.
To distinguish between these possibilities, we performed
RNA in situ hybridization with probes against 16 of the 20
lola isoforms at 0 h after puparium formation (APF), a
developmental time when PNs start to elaborate dendrites
in the AL [4]. We first verified our in situ protocol by using
probes against drifter (dfr), a TF that has previously been
shown to be expressed in GH146 labeled lPNs but not
adPNs [13]. As expected, we found that signal from anti-
sense probe against dfr mRNA coincides with green fluo-
rescent protein (GFP)-labeled lPNs but not adPNs (see
additional file 3). A sense control probe shows little signal
coinciding with the GFP-positive cell bodies (see addi-
tional file 3). We then performed in situ analysis with lola
probes. A probe to the lola common region shows expres-
sion throughout the brain (Figure 4a1,a3) compared with
sense control (Figure 4a2), consistent with our Lola anti-
body staining results. For individual isoform mRNAs, we
detect signal in the region of the AL for all lola isoforms
tested, as well as other brain regions. Some isoforms have
narrower domains of expression, such as isoforms N (see
additional file 3) and T (Figure 4d1,d3), which have much
Axon wiring defects in lola-/- MARCM clones Figure 3
Axon wiring defects in lola-/- MARCM clones. Representative confocal images of (a) wild-type control and (b) lola-/- adNB (1), 
lNB (2) vNB (3) and DL1 SC (4) clones showing PN axons near their normal target: the mushroom body (MB) and lateral horn 
(LH), both marked by blue dotted circles. (c) Example of an axon mistargeting to SOG after exiting the posterior AL (blue dot-
ted circle). Double-headed white arrow demarks dendritic mistargeting to SOG. Blue arrows denote a lack of correct targeting 
while yellow arrows demark ectopic branching. anti-CD8::GFP in green, anti-nc82 neuropil in magenta. Scale bar, 20 μm. (d) 
Quantification of severity of axon targeting defects. Mild: axons target correctly but have ectopic branches (b1, b2); medium: 
axons target to the correct region but follow an incorrect trajectory or bifurcate (b3, b4); severe: axons target to the SOG or 
abnormal brain regions (c).
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stronger signal in the central brain and weaker staining in
the optic lobe. Other isoforms appear to be expressed
more uniformly throughout the region of the AL (Figure
4; see additional file 3). It should be noted that several iso-
forms have more punctate signal that co-localizes with the
nucleus (see additional file 3f, k, r), perhaps indicative of
pre-mRNA. Another caveat is that mRNA production may
not translate to protein expression, as recently shown by
the wide mRNA but narrow protein expression domains
of nerfin [31]. We did not find PN lineage-specific expres-
sion for any of the lola isoforms, nor is there evidence that
any isoforms are expressed in a subset of PNs within a lin-
eage. Rather, most lola  isoform mRNAs appear to be
expressed in all PNs, consistent with scenario III (see addi-
tional file 3).
As an independent and more quantitative method of
assessing expression of different isoforms in PNs, we per-
formed laser-dissection microscopy (LCM) to capture
GH146-positive PNs from frozen sections of 0 h APF tis-
sue, followed by quantitative RT-PCR to detect the expres-
sion level of individual isoforms. Although we do not
have single-cell resolution, laser-dissection allows us to
assay mRNA expression in a small subset of neurons. Con-
sistent with the in situ hybridization data, at 0 h APF we
detected most lola isoforms by RT-PCR, although several
isoforms are near the RT-PCR detection limit (Figure 4e).
We find marked differences (up to 100-fold) in the level
of RNA expression of individual isoforms in PNs at 0 h
APF (Figure 4e). We additionally analyzed AL samples
from different developmental timepoints (third instar lar-
vae, 0 h APF, 25 h APF and adult) and find that expression
levels of several lola isoforms, for example isoform E, H, I,
L, M and Q, appear to be developmentally regulated (see
additional file 4). Our in situ results also suggested that
lola isoforms are expressed at different levels in the optic
lobe. Indeed, RT-PCR on LCM captured optic lobe at 0 h
APF confirmed that mRNAs of different lola isoforms are
expressed at different levels and revealed differences in the
pattern of isoform expression between AL and optic lobe
samples (see additional file 4). Together, these data sug-
gest that the level of individual lola isoform expression is
dynamically regulated and that individual isoforms may
function at different stages in development.
UAS-lola transgene overexpression phenotypes
Genetic analysis using available isoform-specific alleles
(see additional file 1) indicates that at least two isoforms
(K and L) are not required for dendritic targeting of the
majority of PN classes. To test further potential functions
of different isoforms, we examined the overexpression
phenotypes of three lola isoforms. Previous reports sug-
gested differences between the overexpression phenotypes
of lola A and lola T in motor neurons [25]. We have gener-
ated a third transgene, UAS-lola L. We found that Gal4-
GH146 expression of any of these three UAS transgenes
results in lethality, but we bypassed this lethality by
MARCM mediated transgene expression in specific neu-
roblast lineages or single cells (Figure 5; see additional file
5). We tested one, three and two insertions for UAS-lola A,
UAS-lola L and UAS-lola T, respectively (see Table S1 in
additional file 2). Levels of transgene expression were ver-
ified in our attempted rescue experiments (see below).
Because Gal4-GH146 drives transgene expression in post-
mitotic PNs (J Liu, MS, LL, unpublished observation), the
overexpression phenotypes we describe below are caused
by post-mitotic expression of lola transgenes.
Neuroblast or single cell clones overexpressing UAS-lola A
(which lacks a Zn-finger) do not exhibit detectable defects
(Figure 5b; see additional file 5). However, UAS-lola L and
UAS-lola T (which both have C2HC-C2H2-type Zn-fingers)
show strong targeting defects in adPN and lPN neuroblast
clones (see additional file 5). Phenotypes often include a
large increase in wandering dendrites in the AL and some
degree of loss of targeting and ectopic targeting. Often
dendrites appear to be largely restricted to one region of
the AL such as dorsal or lateral, and have wandering den-
drites through this region in many glomeruli, but fail to
innervate normal targets or extend any dendrites into
other regions of the AL (see Additional file 5c, e, f). UAS-
lola T expression also results in a decrease in the number
of labeled PNs, in part likely due to cytotoxicity based on
the observation of clones with very punctate GFP staining
patterns indicative of cell and process degeneration,
although we were unable to reliably stain brain tissues for
activated caspase-3 (V Trunova and E Giniger, unpub-
lished data). Due to the difficulty in quantifying pheno-
types in adPN and lPN neuroblast clones because of the
magnitude and variability, we focused our analysis on
vPN neuroblast clones and single-cell DL1 clones.
vPN neuroblast clones in animals raised at 25°C show no
defects when overexpressing lola A (Figure 5b1) and weak
phenotypes when overexpressing lola L (Figure 5c1), but
vPNs are strongly affected by lola T overexpression (Figure
5e1,f1). Targeting to DA1 is often lost in vPN clones over-
expressing  lola T (Figure 5e1,f1,g). vPN dendrites fre-
quently extend outside of the AL boundary, most often in
the ventral region projecting towards the SOG. Processes
of the pan-AL vPN are not elaborated properly and only
partially innervate the AL.
DL1 single-cell clones were used to examine cell-autono-
mous overexpression effects on both dendritic and axonal
targeting. lola A overexpression did not affect targeting of
either DL1 axons or dendrites (Figure 5b2,b3). The DL1
dendrites targeted correctly with lola L overexpression, but
frequently showed a large increase in dendritic mass out-
side of DL1, wandering throughout the AL (Figure 5c2,h).Neural Development 2007, 2:14 http://www.neuraldevelopment.com/content/2/1/14
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Expression of lola isoforms in the Drosophila brain Figure 4
Expression of lola isoforms in the Drosophila brain. (a-d) RNA in situ analysis of lola isoforms. (a1) An antisense probe generated 
against the common region of lola labels uniformly throughout the brain at 0 h APF. (a2) A sense control to the same probe 
shows little specific staining. (a3) A magnified view of the AL reveals lola expression in all PN cell bodies. PN cell bodies are 
marked by white arrows, while dotted while lines demark the rough area of the AL neuropil in each section that is not stained 
by DAPI. Midline to the left, lateral to the right. Isoform specific probes to isoform L (b), isoform Q (c) and isoform T (d) show 
different patterns of expression throughout the brain at 0 h APF, while sense control probes (b2-d2) show little specific labeling. 
Closer inspection of AL regions at a higher magnification (b3-d3) reveals that most isoforms appear to be expressed in PNs. 
Scale bars: 20 μm (a3-d3); 200 μm (a1-d2). DIG-labeled RNA probe in red, DAPI in blue, GFP in green. See Additional file 2 for 
in situ analysis of additional lola isoforms and additional labeling of section morphology. (e) Quantitative RT-PCR of laser-cap-
tured PN enriched-samples verifies in situ results that most isoforms are expressed in PNs. Additionally, different lola isoforms 
are expressed at different levels at 0 h APF, with about 100-fold difference between highest and lowest expression levels. Data 
are displayed by lola isoform on the X-axis and by relative abundance on a log scale on the Y-axis, where relative abundance has 
been determined against the level of actin42 expression. Error bars represent the standard deviation from four independent 
samples, and each sample was tested independently five times per device. Horizontal solid line represents a confidence limit of 
the average relative expression of samples near the detection limit based on CT values and reproducibility.
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Effects of overexpressing different lola isoforms on dendritic and axonal phenotypes Figure 5
Effects of overexpressing different lola isoforms on dendritic and axonal phenotypes. Representative confocal images of (a) 
control and (b-f) Gal4-GH146 MARCM overexpression phenotypes in vNB (1), DL1 (2) and DL1 axon (3). UAS-lola A (b) over-
expression shows little defects, whereas UAS-lola L (c) and UAS-lola T (d-f) show defects in most classes of PNs. The effect of 
UAS-lola T (d-f) expression increases with increasing temperature. anti-CD8::GFP in green, anti-nc82 neuropil in magenta. Scale 
bar, 20 μm. Blue circles demark a loss of correct targeting, while yellow arrows demark off-target innervation or branching. (g) 
Quantification of vNB targeting phenotypes. Data are presented as percentage of observed clones that innervate a given target. 
Overexpression of UAS-lola T at 25°C or 29°C results in a decrease in DA1 targeting and an increase in ectopic dendritic 
extensions to the SOG. (h, i) Quantification of DL1 phenotypes. Dendrite defects are quantified (h) by percent of clones that 
fail to target DL1 and those that target DL1 but have additional dendrite extensions and ectopic innervations in the AL. Axon 
defects (i) are quantified as in Figure 3.
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In axons, overexpression of lola L often resulted in an
increase in branching in MB and LH regions (Figure
5c3,i). In the LH, these additional branches resulted in a
loss of the stereotypic 'L' projection and a failure of
branches to fully extend into normal target areas. lola T
overexpression resulted in variable DL1 phenotypes, rang-
ing from a complete loss of DL1 innervation and targeting
to other regions of the AL to DL1 targeting with dendritic
extensions outside of the DL1 glomerular region (Figure
5e2,f2,h). lola T overexpression also affected axon target-
ing, most often resulting in a high degree of ectopic
branching, axon bifurcation and incorrect LH innervation
patterns (Figure 5e3,f3,i). It is interesting to note that iso-
forms L and T are normally expressed at low levels based
on RT-PCR results, while isoform A is expressed roughly
10-fold higher (Figure 4e). Differences in overexpression
phenotype may be related to the presence or absence of a
Zn-finger domain, and/or to the expression level relative
to the endogenous level of expression.
UAS-lola T dosage sensitivity
In the course of our overexpression study, we tested two
different insertions of UAS-lola T. We noticed that the
insertion on the third chromosome gives stronger and
more penetrant phenotypes than the insertion on the X
chromosome, and hypothesized that this was due to dif-
ferences in transgene expression levels. To test this hypo-
thesis, we altered the levels of UAS-lola T (X insertion)
transgene expression by raising animals at 18°C, 25°C or
29°C, as levels of Gal4-induced transgene expression
increase with increasing temperatures. In neuroblast
clones we observed a qualitative increase of phenotypic
severity in both dendritic and axonal targeting with
increasing temperature (Figure 5d,e,f). This dosage sensi-
tivity can be quantified with the DL1 dendritic pheno-
types (Figure 5h). Flies raised at 18°C have few dendritic
phenotypes, while at 25°C and 29°C dendrites mistarget
and have ectopic innervations and axons have additional
branches and bifurcations (Figure 5h,i; see Table S1 in
additional file 2). Additionally, dosage sensitivity is evi-
dent in vNB DA1 and SOG extension phenotypes (Figure
5g). This experiment indicates that PN dendritic targeting
is sensitive to the expression level of a specific lola iso-
form.
Individual lola isoform expression in a lola null background
To test if individual lola isoforms can rescue any of the lola-
/- phenotype, we performed MARCM analysis on clones
that are simultaneously lola-/- and express either UAS-lola
A, UAS-lola L or UAS-lola T transgenes. We verified all
transgenes are expressed based on the presence of Lola
antibody staining in these otherwise lola-/- clones. Expres-
sion of all transgenes was qualitatively similar at a level
roughly half as intense as neighboring non-mutant cells
expressing endogenous levels of Lola (data not shown).
Instead of rescuing the lola-/- phenotype, overexpression of
transgenes in mutant PNs resulted in additive defects (Fig-
ure 6; see additional file 6). In adPN and lPN neuroblast
clones, simultaneous loss of endogenous lola and expres-
sion of any of the single isoforms caused striking additive
effects in cell loss and lack of dendritic extension, which
are described in detail in additional file 6. Below we focus
on vPN neuroblast clones and DL1 single cell clones.
Additive effects of transgene expression were most striking
in vPNs. lola-/- vPNs expressing UAS-lola A, UAS-lola L or
UAS-lola T resulted in strong reduction of VA1lm and DA1
targeting (Figure 6f). Additionally, the pan-AL neuron
often showed little dendritic process elaboration and
rarely innervated much of the AL. Dendrites and axons of
ventral cells often looked punctate, indicative of degener-
ation. These data indicate that expression of UAS trans-
genes in lola-/- clones fails to rescue lola phenotypes and
further disrupts dendritic wiring. Additionally, expression
of certain lola isoforms alone may be toxic, perhaps due to
dominant-negative interactions with other proteins or lola
dimerization.
DL1 clones were difficult to obtain for all UAS-lola trans-
genes expressed in lola-/- clones, possibly due to toxicity
that we observe in neuroblast clones. Phenotypes did not
always appear additive for DL1 clones, perhaps due to low
levels of MARCM-based expression in single cell clones
during the critical time of dendritic and axonal targeting.
The strongest dendritic phenotypes were observed in lola-
/- cells expressing UAS-lola T, where every clone either
failed to innervate DL1 or had extensions into other
regions of the AL (Figure 6e,g). lola-/- cells expressing UAS-
lola L innervated DL1 in addition to having extensive den-
dritic innervation in the rest of the AL, while lola-/- cells
expressing UAS-lola A were variable, with half appearing
normal (Figure 6c,d,g). All lola-/- cells expressing a UAS-
lola transgene showed axonal defects, ranging from a fail-
ure to extend or elaborate branches in the LH to an
increase in ectopic branching (Figure 6h). These pheno-
types suggest that individual lola isoforms can function
post-mitotically to disrupt dendrite and axon targeting in
DL1, and suggest that Lola interacts either as homomers
or with other BTB domain proteins. Additionally, expres-
sion of single lola isoforms, especially lola T, appears to be
toxic to many cells, so it is unclear if phenotypes are
directly related to targeting or perhaps secondary effects
due to disruption of cell viability.
Taken together, these results suggest that isoform diversity
of the lola locus is important. Post-mitotic expression of a
single isoform is not sufficient to rescue the lola pheno-
type, and indeed is more disruptive to a cell than simple
loss of lola. This does not, however, rule out an additional
function of Lola in the neuroblast. Lastly, some aspects ofNeural Development 2007, 2:14 http://www.neuraldevelopment.com/content/2/1/14
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UAS-transgene overexpression in lola-/- MARCM clones results in additive dendritic and axonal targeting defects Figure 6
UAS-transgene overexpression in lola-/- MARCM clones results in additive dendritic and axonal targeting defects. Representa-
tive images of (a) control and (b-e) experimental conditions as indicated for the vNB (1), DL1 single-cell dendrite (2) and axon 
(3) phenotypes of UAS-lola A (c), UAS-lola L (d) and UAS-lola T (e) expression in lola-/- MARCM clones. None of the transgenes 
are able to rescue the lola-/- phenotype. Expression of either UAS-lola A and UAS-lola T both result in a decrease in dendrite elab-
oration. (f) Quantification of vNB phenotypes. Data are presented as percentage of observed clones that innervate a particular 
target. UAS-lola transgenes fail to rescue the lola-/- phenotype. Often transgene expression has an additive effect and further dis-
rupts normal targeting, for example, there are dramatic losses of VA1lm targeting with UAS-lola A and UAS-lola T. 'N' for rescue 
experiments are low due to extreme difficulty in generating MARCM UAS-expression clones in a lola-/- background. (g) Quan-
tification of DL1 dendrite phenotypes as in Figure 5. UAS-lola L and UAS-lola T clones lack normal dendritic targeting. (h) Quan-
tification of DL1 axonal phenotypes as in Figure 2. UAS-lola L and UAS-lola T show increases in axonal defects compared with 
lola-/- alone. anti-CD8::GFP in green, anti-nc82 neuropil in magenta. Scale bar, 20 μm.
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Lola function are likely mediated through the BTB
domain alone, as additive phenotypes can be caused by
expressing isoforms with or without Zn-fingers.
Evidence that lola regulates cell identity and transcription
The dendritic and axonal phenotypes in lola-/-clones we
described so far could be caused by the action of Lola on
PN targeting directly (for instance, by regulating the
expression of cell surface receptors), or Lola could regulate
PN identity with axonal and dendritic mistargeting as a
secondary consequence. Although these models are not
mutually exclusive, we provide some evidence in lola-/-
MARCM clones using several Gal4 lines, including Mz19,
GH146 and NP3529, to support the second hypothesis.
MARCM with several mutant alleles suggests that lola reg-
ulates the expression of Gal4-Mz19. Ten percent of
lolaore5D2 (lola hypomorph) and lola-/- clones show a 30%
to 50% increase in the number of labeled PNs and tar-
geted glomeruli (Figure 7a2,a3; MARCM control Figure
2a5,a6). Strikingly, we observed (in 64% of all adPN
clones) that lola L-/-(lolaore119) clones frequently target the
DL1 glomerulus (Figure 7a5), which is normally targeted
by GH146 positive, but never Mz19 positive, PNs. As our
heat-shock timing in these experiments should not result
in any Mz19 single cell clones (they are born later) but
coincides exclusively with the birth of the DL1 PN [2], the
simplest interpretation is that Mz19 is now misexpressed
in DL1 PNs. This would suggest that lola  normally
represses Mz19 expression in DL1 PNs. As additional evi-
dence that lola regulates gene expression, 25% of clones of
both lola-/- and lola L-/-visualized by Gal4-Mz19 appear to
label local interneurons (LNs), an additional cell-type that
innervates a large number of glomeruli in the AL and lacks
axonal projections out of the AL region (Figure 7a4,a6).
The similarity of isoform L specific phenotypes to pheno-
types in other lola alleles suggests that lolaore119 pheno-
types in PNs might be caused by the disruption in isoform
L instead of a second site mutation on the same chromo-
somal arm. Thus, it appears that in the absence of Lola
(particularly the Lola L isoform), Gal4-Mz19 is ectopically
expressed in neuronal types that normally do not express
this Gal4 enhancer trap line.
Gal4-GH146, used extensively in this study, labels a large
subset of PNs in the AL, roughly 50 adPNs, 35 lPNs and 5
or 6 vPNs (Figure 7b1; MARCM controls Figure 2a1–3).
However, in lola-/- neuroblast clones we observe labeling
of a new cell type that innervates a small region of the AL
and sends projections to the medial axonal lobe of the MB
as well as the central body complex (Figure 7b2–3). These
cells are never labeled in control experiments, but make
up 22% of all observed clones in lola-/- experiments (see
Table S5 in additional file 2). Interestingly, we observe
similar projection patterns in wild-type neurons labeled
with other Gal4 drivers, suggesting that central body com-
plex targeted lola-/- clones are a different cell type where
Gal4-GH146 expression is normally repressed by lola.
Gal4-NP3529 labels two dorsal PNs that project to DL1
(Figure 7c1). Clones generated with both lola-/- and lola L-
/- label much larger subsets of cells. These clones often
contain PNs that innervate typical GH146 target glomer-
uli, as well as LNs and other PN classes that do not express
GH146. lola-/- clones label many additional cells in the
adPN lineage as well as lPNs and LNs (Figure 7c2). lola L-
/- clones show similar types of mislabeling (Figure 7c3).
This strongly suggests that lola function is normally neces-
sary to repress the expression of NP3529 in multiple cell
types.
Lola also appears to positively regulate gene expression.
Lim1 is expressed in a subset of PNs, including most (at
least four) vPNs labeled by GH146 (Figure 7d1,d2) [14].
In  lola-/- mutant cells, Lim1 expression is lost (Figure
7e1,e2). Lim1 expression cannot be rescued by expression
of either UAS-lola A or UAS-lola T in lola-/- clones (n = 2
each for UAS-lola A and UAS-lola T; data not shown). Lim1
expression is also lost in vPNs mutant for the TF cut [14].
However, Cut expression is not altered in lola-/-clones, and
Lola expression is not altered in cut-/-clones (data not
shown), suggesting these TFs coordinately regulate Lim1
expression through parallel pathways. Intriguingly, PNs
mutant for lola, lim1 or cut all fail to target DA1, suggesting
that cut and lola may be necessary for regulation of other
TFs as well as wiring. Antibody staining patterns of other
TFs previously identified to be important for PN targeting,
including acj6, drifter, cut, chip and islet, are not disrupted
in lola-/- clones (data not shown). Taken together, these
data suggest that lola can positively and negatively regulate
gene expression of other genes known to label subsets of
PNs or to play a role in PN wiring specificity.
Conclusion
Wiring specificity in Drosophila olfactory projection neu-
rons is regulated by intrinsic TFs [13-15]. Here we have
characterized an additional TF, Lola, as necessary for
proper AL wiring specificity of both PN dendrites and
axons. lola-/- mutant clones show a wide variety of wiring
phenotypes, including a loss of targeting to correct
glomeruli, innervation of ectopic targets, a loss of lineage
restriction in dendritic projections, a loss of AL boundary
restriction, and an increase in wandering projections and
ectopic branch formation. Additionally, lola appears nor-
mally to repress the expression of multiple Gal4 drivers in
certain cell-types and positively regulate lim1  in vPNs.
These data suggest that lola regulates multiple develop-
mental processes, including identity as well as wiring spe-
cificity of PNs, consistent with its expression in
neuroblasts and post-mitotic neurons. In fact, the wideNeural Development 2007, 2:14 http://www.neuraldevelopment.com/content/2/1/14
Page 14 of 19
(page number not for citation purposes)
Evidence that lola regulates expression of Gal4 drivers and Lim1 Figure 7
Evidence that lola regulates expression of Gal4 drivers and Lim1. (a) Gal4-Mz19 mislabeling analysis. Whole-animal Gal4-Mz19, 
UAS-GFP::CD8 expression labels a small subset of PNs (a1). See Figure 2 for Mz19 and GH146 MARCM controls. Mutations in 
lola result in the labeling of more cell bodies than Mz19 normally labels (hypo: ore5D2) (a2, a3), as well as the labeling of ectopic 
cell types such as local interneurons (LNs) (a4, a6) and DL1 that is normally labeled by Gal4-GH146 but not Gal4-Mz19 (a5). (b) 
lola-/- Gal4-GH146 clones frequently mislabel a set of neurons in the region of the AL that project to the medial lobe of the MB 
and to the central body complex. (c) NP3529 mislabeling analysis. NP3529 labels two dorsal PNs that project to DL1 (c1). lola-
/- clones dramatically increase the number of cells labeled near the AL, including cells in the lateral lineage and LNs (c2). lolaL-/- 
clones show similar mislabeling (c3). anti-CD8::GFP in green, anti-nc82 neuropil in magenta. (d, e) lola regulates Lim1 expres-
sion in vPNs. Wild-type cells in the region of the antennal lobe, including most (at least four) vPNs express Lim1 (d). In lola-/- 
cells, Lim1 expression is lost in vPNs (e). Note that the lola-/-clone includes neighboring cells in addition to those labeled by 
Gal4-GH146, and many cells have lost Lim1 staining. White arrows mark the cell bodies of GFP positive cells. anti-CD8::GFP in 
green, anti-Lim1 in magenta, DAPI in blue. Scale bar, 10 μm.
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variety of phenotypes observed in lola mutants may be a
general characteristic of genes involved in multiple devel-
opmental processes, as similar phenotypes are observed
in mutants of general TF complex cofactors, such as chip
[14], or are known chromatin regulatory genes (D Berdnik
and LL, unpublished data). This is the first report linking
roles for lola in both fate and wiring specificity in the same
cell-type, suggesting that PNs have a tightly linked rela-
tionship between targeting specificity and cell identity.
lola is a highly complex genetic locus and encodes at least
20 different splice isoforms [16]. Although Lola is
expressed throughout development, quantitative RT-PCR
reveals that individual isoforms have different levels of
expression. The diversity of lola isoform expression in PNs
also appears important, as expression of a single UAS-lola
transgene fails to rescue null mutant phenotypes and
often results in even more severe phenotypes that are spe-
cific to the expressed lola isoform. We tested available iso-
form-specific lola alleles, and found that an isoform L (but
not K) mutant has mild targeting defects. The difficulties
of generating other isoform-specific alleles in this locus,
coupled with the strong gain-of-function effect of express-
ing transgenes of a single isoform, made it difficult for us
to investigate further isoform-specific functions of lola in
PN development. However, taken together with previous
reports [16,25,16,25], our results support the notion that
different isoforms may have unique functions in PNs in
addition to embryonic motor neurons.
Several lines of evidence suggest that Lola can regulate
chromatin structure. Loss of function (LOF) mutations in
lola enhance the Pc/+ phenotype and result in a significant
increase in the number of sex-combs on the second leg, as
do other known PcG factors [28]. This reported PcG inter-
action, in addition to direct binding of the chromosomal
kinase JIL-1 and the presence of the nucleosome binding
C2HC class Zn-finger [20,21], suggests that at least some
Lola isoforms may be part of chromatin regulatory com-
plexes. Additionally, at least one Lola isoform has been
shown to bind directly to DNA and regulate expression of
the copia retrotransposon [22]. Many chromatin regula-
tors are integral components in pathways of cell fate spec-
ification. Neuronal cell fate is closely linked with
dendritic and axonal targeting, particularly in PNs where
cell identities based on birth order are manifested as wir-
ing choices and target specification [2]. This link between
targeting and cell identity has been suggested in the MB,
where mutation of the chromatin modifier polyhomeotic
causes MB neurons to randomly express certain Hox genes
that are normally suppressed and to display a wide variety
of axon targeting defects that are neither a complete target-
ing fate switch nor consistent between individuals [32].
This is reminiscent of the lola phenotype in PNs, suggest-
ing that lola might function in a similar manner.
lola may additionally play a more direct role in targeting.
lola  mutants affect some glomeruli more severely than
others and have post-mitotic functions in DL1 dendritic
targeting, suggesting that there is a differential require-
ment for, or sensitivity to, the loss of lola between individ-
ual PNs. lola also has specific targeting phenotypes in the
embryonic central and peripheral nervous systems, as
mutations in lola  seem to disrupt axon guidance and
extension of the Ap+, VUM, and ISNb neurons without
affecting the numbers or differentiation of these neuronal
subtypes [16,24,25,29]. Taken together, this evidence sug-
gests that lola may participate both in fate determination
and, more directly, in wiring specificity. If the processes of
fate determination and wiring specificity are separable,
one might expect a factor that controls wiring to directly
regulate the expression of genes that function in targeting,
such as cell surface receptors, while a factor that controls
cell fate should affect the expression of 'fate' markers that
subsequently disrupt downstream expression of the com-
ponents of the wiring machinery in an indirect fashion.
Future identification of direct targets of lola regulation will
be informative and necessary to understand the exact
mechanism of lola function in PNs.
The idea that TFs can differentially control fate specifica-
tion and wiring specificity is consistent with the model of
a hierarchical TF code that determines wiring specificity. It
is interesting to consider the possibility that some TFs may
be used at multiple points during identity and wiring
specification. In neuron sub-type specification in the ven-
tral nerve cord, the TF collier specifies the precursors of the
Ap neuron subset, but must be turned-off in three of the
four Ap cells as subsequent participation of collier in a
multi-protein complex later in development defines a
unique sub-type of Ap neurons [33]. During development
of the peripheral nervous system, cut  specifies sensory
neuron identity and is required again later in develop-
ment at different levels in subpopulations of dendritic
arborization neurons to specify subclass arborization
[34]. Similarly, in vPN development, the TF Cut is neces-
sary in the neuroblast for generation of the correct
number of vPNs and postmitotically for specific targeting
of the VA1lm glomerulus [14]. Temporal regulation and
multi-functionality of TFs are possible mechanisms to
limit the required number of genes in a TF code while still
uniquely specifying cell identity. Lola is a potential candi-
date for a TF that may function in this way, both specify-
ing cell identity and playing more specific roles later in
development in regulating wiring specificity.
Methods
Fly stocks and reagents
MARCM stocks used were as previously published [35].
Gal4-GH146 and Gal4-Mz19 are available from the
Bloomington Stock Center, and Gal4-NP3529 is from theNeural Development 2007, 2:14 http://www.neuraldevelopment.com/content/2/1/14
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Kyoto Stock Center. lolaore76 (early stop codon in BTB
domain predicted to be protein null for all Lola isoforms),
lolaore119 (Pro712 to Leu mutation in the Zn-finger linker
region of isoform L predicted to reduce DNA binding by
95%), lolaorc4 (C to T transition introduces an early stop in
amino acid 771 of isoform K), lola5D2 (P-element inser-
tion into the lola promoter predicted to be strongly hypo-
morphic allele and eliminate most lola  transcription),
UAS-lola A (X), UAS-lola T (X) and UAS-lola T (III) have
been described previously [16,24,25]. We generated three
new UAS-lola L lines with insertions on chromosome III.
The lola L coding region was cloned into p [UAST] [36]
and injected into embryos. Single G0 males were crossed
to yw; Pin/CyO virgins. Single F1 males with red eyes were
crossed to yw; Pin/CyO virgins to establish stocks and
identify the insertion chromosome.
Genotypes of flies generated in experiments are as follows:
(Lola protein expression time course and Lim1 WT stain-
ing) yw; Gal4-GH146, UAS-mCD8a::GFP (GH146 stain-
ing and LOF analyses) hsFlpCD8; FRT42D, Gal80/
FRT42D, lolax, GH146, UAS-mCD8a::GFP  [where x
denotes any lola  allele] (control GH146 MARCM)
hsFlpCD8; FRT42D, Gal80/FRT42D, GH146, UAS-
mCD8a::GFP (lolaORC4 LOF analysis) hsFlpCD8; FRT42D,
Gal80/FRT42D, lolaorc4, GH146, UAS-mCD8a::GFP (con-
trol Mz19 MARCM) hsFlpCD8; Gal4-Mz19, UAS-
mCD8a::GFP, FRT42D, Gal80/FRT42D (Mz19 LOF analy-
sis) hsFlpCD8; Gal4-Mz19, UAS-mCD8a::GFP, FRT42D,
Gal80/FRT42D, lolax (UAS-lola A misexpression) UAS-lola
A/hsFlp122, UAS-mCD8a::GFP; FRT42D, Gal80/FRT42D,
Gal4-GH146, UAS-mCD8a::GFP (UAS-lola L (X) misex-
pression)  UAS-lola T/hsFlp122,  UAS-mCD8a::GFP;
FRT42D, Gal80/FRT42D, Gal4-GH146, UAS-
mCD8a::GFP  (UAS-lola T (III) misexpression) hsFlp122,
UAS-mCD8a::GFP; FRT42D, Gal80/FRT42D, Gal4-
GH146, UAS-mCD8a::GFP; UAS-lola T (UAS-lola L misex-
pression) hsFlp122,  UAS-mCD8a::GFP; FRT42D, Gal80/
FRT42D, Gal4-GH146, UAS-mCD8a::GFP;  UAS-lola L
(UAS-lola A rescue)  UAS-lola A/hsFlp122,  UAS-
mCD8a::GFP; FRT42D, Gal80/FRT42D, lolaORE76, Gal4-
GH146, UAS-mCD8a::GFP (UAS-lola T rescue) UAS-lola T/
hsFlp122,  UAS-mCD8a::GFP; FRT42D, Gal80/FRT42D,
lolaORE76, Gal4-GH146, UAS-mCD8a::GFP  (UAS-lola L
rescue) hsFlp122,  UAS-mCD8a::GFP; FRT42D, Gal80/
FRT42D, lolaORE76, Gal4-GH146, UAS-mCD8a::GFP; UAS-
lola L (NP3529 LOF analysis) hsFlp122,  UAS-
mCD8a::GFP;FRT42D, Gal80/FRT42D, lolax;Gal4-
NP3529.
Clonal and phenotypic analysis
MARCM was performed as previously described [30,35].
Clones were induced at 24 h APF for all Gal4 driver lines.
Brains were dissected, fixed in 4% paraformaldehyde for
20 minutes at room temperature and stained. Brains were
mounted in Slow-Fade Gold or BioMedia Mounting
Medium and imaged on a Zeiss LSM Meta 510 system. Z-
series were captured in 1 μm sections. Fluorophores were
imaged using band-pass filters to remove cross-detection
between channels and pseudocolored for ease of viewing.
Images were processed and scored using Image J [37] or
Zeiss software. Data were analyzed using FileMaker Pro
and Microsoft Excel. In all, we scored 48 distinct glomer-
uli in the AL, based on published models [38]. Glomeruli
were considered innervated when dendrites entered the
nc82 stained synaptic dense region and elaborated exten-
sions within the glomerulus (that is, a single extension
passing through a glomerulus was not enough to warrant
scoring as positively innervated).
Antibodies and staining
Antibody staining was performed as previously described
[14,39]. The following primary antibodies were used; rat
anti-mCD8a (Caltag [Burlingame, California, USA]),
1:100; monoclonal antibody (mAb) nc82 (developed by
E Buchner and obtained from the Developmental Studies
Hybridoma Bank (DSHB) [Iowa City, Iowa, USA]), 1:30;
rabbit anti-Lola common region [24], 1:100; mAb anti-
Cut (DSHB), 1:20; guinea pig anti-Lim1 (a gift from J
Botas), 1:500; rat anti-Islet (a gift from J Skeath), 1:1,000;
rabbit anti-Chip (a gift from D Dorsett), 1:500; mouse
monoclonal anti-Acj6 [40], 1:5; rat anti-Drifter [41],
1:3,000; mouse monoclonal 7F1 anti-lola zf5 [21]. Nuclei
were counterstained with DAPI (5 mg/ml stock 1:1,000).
Laser-dissection microscopy and RT-PCR
White y, w; Gal4-GH146, UAS-CD8::GFP pre-pupa (con-
sidered 0 h APF) were collected, covered with optimal cut-
ting temperature compound (Tissue Tek O.C.T. #4583
[Sakura Finetek, Torrance, California, USA]), frozen on
dry ice and stored at -80°C not longer than 1 month.
Blocks were sectioned on a cryostat and sections contain-
ing ALs were mounted on PEN membrane slides (Leica
#11505158) and stored on dry ice. Slides were put
through an EtOH dehydration series (75%, 95%, 100%
EtOH 5 minutes each), treated for 2 minutes with xylenes,
dried and mounted for LCM capture. PN enriched sam-
ples as identified by GFP fluorescence were immediately
captured into PCR tube caps on a Leica LCM microscope
(model ASLMD) using Laser Microdissection software ver-
sion 4.4. Tubes were frozen on dry ice and stored at -80°C
up to one day. RNA was extracted using the Arcturus
PicoPure™ RNA Isolation kit (#KIT0204, Mountain View,
California, USA) as per the manufacturer's instructions.
The cRNA samples were used as the template for another
round of reverse transcription (#18080-051, Invitrogen
[Carlsbad, California, USA]), producing a high yield of
cDNA. The cDNA samples were aliquoted and stored at -
20°C before use. Unique primer pairs and Taqman probesNeural Development 2007, 2:14 http://www.neuraldevelopment.com/content/2/1/14
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were designed for individual lola isoforms. The Taqman
probes were synthesized by Integrated DNA Technologies,
Inc. (Coralville, Iowa, USA). Microfluidic matrix chips (48
× 48 arrays, Fluidigm (South San Francisco, California,
USA) were used to perform real time PCR assays in a high
throughput fashion. Each chip allows complete combina-
torial tests (48 × 48 = 2,304, N = 48) between N independ-
ent cDNA samples and N distinct primer pairs [42]. A
separate paper is to be published with more technical
details.
In situ hybridization
Probes for lola were designed to the common region and
isoform specific exons (for primers see Table S6 in addi-
tional file 2). Isoforms are referred to based on the previ-
ously described naming scheme [16]. Probes were
amplified from adult genomic preps or from embryo RNA
via RT-PCR, topo-cloned and sequenced to verify identity.
DIG-labeled RNA probes were generated from plasmid
DNA using the Roche DIG-RNA Labeling Kit
(#11175025910, Indianapolis, Indiana, USA) following
the manufacturer's protocol. Sense and antisense probes
were generated from the same plasmid, taking advantage
of the SP6 and T7 dual promoter flanked PCR2.1-Topo (#
K460001, Invitrogen) cloning site. Probes were diluted to
10 ng/μl and stored at -80°C for up to 6 months. We col-
lected 0 h APF pre-pupa, which were frozen in OCT on dry
ice, stored at -80°C not more than 1 month and sectioned
on a cryostat. An in-depth protocol for in situ hybridiza-
tion is available in additional file 7. Briefly, slides were
fixed in 4% PFA for 15 minutes, washed, acetylated,
washed, and pre-hybridized at room temperature. Probes
were added at concentrations ranging from 5 ng to 100 ng
and slides were incubated 18 h overnight at 55°C. Slides
were washed, native biotin blocked and blocked in nor-
mal goat serum. Sheep anti-DIG or rabbit anti-DIG and
chicken anti-GFP primaries were added and incubated
overnight at 4°C. Slides were washed, treated with a tyra-
mide signal amplification kit for DIG signal detection
(Dako #K0620 [Carpinteria, California, USA]), then incu-
bated with secondary anti-chicken antibody. Slides were
washed, mounted and imaged.
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